Diabetologia

Papers
(The H4-Index of Diabetologia is 52. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Branding foods as ‘healthy’ or ‘unhealthy’ based on marginal data calls findings into question. Reply to Kanter M [letter]644
Scientists and scientific journals should adhere to ethical standards for the use and reporting of data from Indigenous people358
Critical comments regarding the assessment of quality of life and the clinical impact of the POWER2DM intervention. Reply to Pouwer F, Deschênes SS [letter]283
Up Front193
The SWI/SNF chromatin remodelling complex regulates pancreatic endocrine cell expansion and differentiation in mice in vivo157
Sex-dependent intra-islet structural rearrangements affecting alpha-to-beta cell interactions lead to adaptive enhancements of Ca2+ dynamics in prediabetic beta cells156
Loneliness increases the risk of type 2 diabetes: a 20 year follow-up – results from the HUNT study149
Chronic kidney disease in type 1 diabetes: translation of novel type 2 diabetes therapeutics to individuals with type 1 diabetes147
Glucagon-like peptide-1 receptor agonists reverse nerve morphological abnormalities in diabetic peripheral neuropathy131
Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation study115
Embracing complexity: making sense of diet, nutrition, obesity and type 2 diabetes107
The metabolomic signature of weight loss and remission in the Diabetes Remission Clinical Trial (DiRECT)103
Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation101
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care100
In Memoriam Werner Waldhäusl, 27 September 1937–22 May 202599
Prevention and treatment of ischaemic and haemorrhagic stroke in people with diabetes mellitus: a focus on glucose control and comorbidities87
Determination of autoantibodies in type 2 diabetes: one simple way to improve classification85
Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory85
Cardiovascular risk management among individuals with type 2 diabetes and severe mental illness: a cohort study82
TBC1D30 regulates proinsulin and insulin secretion and is the target of a genomic association signal for proinsulin80
Paediatric diabetes subtypes in a consanguineous population: a single-centre cohort study from Kurdistan, Iraq79
Differences in biopsy-proven diabetic kidney disease in individuals from Polynesia vs mainland France: a retrospective cohort study78
MicroRNA-193b impairs muscle growth in mouse models of type 2 diabetes by targeting the PDK1/Akt signalling pathway77
Ageing well with diabetes: the role of technology74
Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study74
Methodological considerations for interpreting long-term statin use and diabetes incidence73
60th EASD Annual Meeting of the European Association for the Study of Diabetes72
Considerations for more actionable consensus guidance for monitoring individuals with islet autoantibody‑positive pre‑stage 3 type 1 diabetes70
Birthweight, BMI in adulthood and latent autoimmune diabetes in adults: a Mendelian randomisation study69
58th EASD Annual Meeting of the European Association for the Study of Diabetes68
Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trials68
Postprandial hypoglycaemia after gastric bypass in type 2 diabetes: pathophysiological mechanisms and clinical implications67
A simple score-based strategy to improve equity of the UK biennial diabetic eye screening protocol among people deemed as low risk66
Predicting non-insulin-dependent state in patients with slowly progressive insulin-dependent (type 1) diabetes mellitus or latent autoimmune diabetes in adults64
Targeted proteomics identifies potential biomarkers of dysglycaemia, beta cell function and insulin sensitivity in Black African men and women63
Up Front63
Repeated faecal microbiota transplantation for individuals with type 1 diabetes and gastroenteropathy62
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open61
Daniel Porte Jr, 13 August 1931–13 May 202361
Frequency and clinical characteristics of children and young people with type 2 diabetes at diagnosis from five world regions between 2012 and 2021: data from the SWEET Registry60
Pinpointing precision medicine for diabetes mellitus60
Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register – an IMI-SOPHIA study59
Adverse pregnancy outcomes in women with type 1 diabetes are associated with multiple alterations in the vaginal microbiome59
Evaluating the role of alpha cell dysregulation in the progression to type 2 diabetes using mathematical simulations59
Mortality risk for kidney transplant candidates with diabetes: a population cohort study58
GLP-1 receptor agonists in lean diabetes in racial and ethnic minority groups: closing the treatment gap57
Cholesterol crystal formation is a unifying pathogenic mechanism in the development of diabetic retinopathy56
Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial56
Once-weekly IcoSema versus once-weekly semaglutide in adults with type 2 diabetes: the COMBINE 2 randomised clinical trial54
Reassessing the evidence: prandial state dictates glycaemic responses to exercise in individuals with type 1 diabetes to a greater extent than intensity53
Loss of function of renal Glut2 reverses hyperglycaemia and normalises body weight in mouse models of diabetes and obesity53
Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals53
eNAMPT is a novel therapeutic target for mitigation of coronary microvascular disease in type 2 diabetes52
Effects of progressive resistance training in individuals with type 2 diabetic polyneuropathy: a randomised assessor-blinded controlled trial52
Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes52
0.16806483268738